Author name: andrewshd

Podimetrics Inc – Strategic Executive Hires for Growth

Longtime Congresswoman and former President and CEO of the Better Medicare Alliance, Allyson Schwartz, also joins Podimetrics’ Advisory Board SOMERVILLE, Mass., May 12, 2022 — Podimetrics Inc, creator of the FDA-cleared SmartMat™ and integrated clinical care services that can help save the limbs and lives of complex patients with diabetes, today announced four new leadership […]

Podimetrics Inc – Strategic Executive Hires for Growth Read More »

Koya Medical Presents Two Newly Published Clinical Studies for Dayspring Active Compression Treatments at the AVLS 2022 Annual Congress

OAKLAND, Calif., Oct. 24, 2022–Koya Medical, a healthcare company on a mission to transform lymphatic and venous care through a comprehensive suite of innovative, people-centric solutions, presented two newly published clinical studies for the treatment of lymphedema and venous disease with its Dayspring® active compression system that showed significant improvements in patient outcomes. Stanley Rockson,

Koya Medical Presents Two Newly Published Clinical Studies for Dayspring Active Compression Treatments at the AVLS 2022 Annual Congress Read More »

Interim Results of MATCH Study Demonstrate Improved Decision Making and Clinical Outcomes When Using Mind.Px™ to Determine Biologic Drug Class for Psoriasis Patients

By Using Mind.Px, Patients Achieve PASI75 Faster than Treatment-as-Usual Cohort SAN DIEGO, CA – October 20, 2022 – Interim clinical utility and patient outcomes data regarding Mindera Health’s Mind.Px™ test from the ongoing MATCH study were recently presented at the Fall Clinical Dermatology Conference 2022 in Las Vegas, one of the largest US-based dermatology educational

Interim Results of MATCH Study Demonstrate Improved Decision Making and Clinical Outcomes When Using Mind.Px™ to Determine Biologic Drug Class for Psoriasis Patients Read More »

Eirion Therapeutics Announces Initiation of First-in-Human Clinical Trial

Eirion Therapeutics Announces Initiation of First-in-Human Clinical Trial Evaluating Next Generation, Ready-to-Use Liquid Injectable Neuromodulator AI-09 for the Treatment of Wrinkles Company Also Announces Update for Its Lead, Phase 2b Product Candidate Topical Neuromodulator ET-01 Oct 17, 2022 – Woburn, MA Eirion Therapeutics Inc. announced today that the first participants have been dosed in a

Eirion Therapeutics Announces Initiation of First-in-Human Clinical Trial Read More »

Published Studies Reveal New Data About Edema Reduction,Patient Satisfaction and Quality of Life With Dayspring System

OAKLAND, Calif., Oct. 4, 2022 —Koya Medical, a healthcare company on a mission to transform lymphatic and venous care through a comprehensive suite of innovative, people-centric platforms, today announced two clinical data publications for the treatment of lymphedema and venous disease with its Dayspring® active compression system, including results from the multi-center, randomized, crossover head-to-head

Published Studies Reveal New Data About Edema Reduction,Patient Satisfaction and Quality of Life With Dayspring System Read More »

LimiFlexTM IDE Clinical Trial Investigator to Present Positive Findings at the North American Spine Society Annual Meeting — Empirical Spine

San Carlos, Calif. (October 6, 2022) – Empirical Spine, Inc., a medical device company creating a new class of spinal implant that works in parallel with the natural structures of the spine to restore functionality and optimize quality of life, will highlight its LimiFlex™ Dynamic Sagittal Tether™ (DST) at the North American Spine Society (NASS)

LimiFlexTM IDE Clinical Trial Investigator to Present Positive Findings at the North American Spine Society Annual Meeting — Empirical Spine Read More »

Channel Medsystems Announces First Endometrial Ablation Procedures in Europe with the Cerene® Cryotherapy Device

Channel Medsystems Announces First Endometrial Ablation Procedures in Europe with the Cerene® Cryotherapy Device BERKELEY, Calif., DATE – Channel Medsystems, Inc., a medical device company whose mission is to empower every woman to take control of her health journey, today announced that the first procedures in Europe were performed with the Cerene® Cryotherapy Device for

Channel Medsystems Announces First Endometrial Ablation Procedures in Europe with the Cerene® Cryotherapy Device Read More »

Sight Sciences Announces Publication of Data Showcasing Superior Symptoms Improvements with the TearCare® System Compared to LipiFlow* in Patients with Advanced Dry Eye Disease (DED)

MENLO PARK, Calif., Sept. 29, 2022 (GLOBE NEWSWIRE) — Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform care and improve patients’ lives today announced Clinical Ophthalmology has published data from a subgroup analysis of the OLYMPIA trial, which showed a single treatment with the TearCare System

Sight Sciences Announces Publication of Data Showcasing Superior Symptoms Improvements with the TearCare® System Compared to LipiFlow* in Patients with Advanced Dry Eye Disease (DED) Read More »

Potrero Medical Receives FDA Breakthrough Device Designation for Accuryn AKI Predict Algorithm

HAYWARD, Calif., Sept. 13, 2022 – Potrero Medical announced today that the FDA granted Breakthrough Device Designation for their AKI Predict machine learning algorithm, for the advanced prediction of acute kidney injury (AKI) associated with intra-abdominal hypertension (IAH) in cardiac post-surgical intensive care patients. “We are excited about the designation, and what this means for patients, providers

Potrero Medical Receives FDA Breakthrough Device Designation for Accuryn AKI Predict Algorithm Read More »

Sight Sciences Introduces the SION™ Surgical Instrument – The First Bladeless Device Used in Goniotomy

MENLO PARK, Calif., August 23, 2022 (GLOBE NEWSWIRE) — Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on developing and commercializing innovative solutions intended to transform care and improve patients’ lives, today announced the launch of SION, a surgical instrument representing a new chapter in goniotomy innovation and practice. Sight Sciences is a

Sight Sciences Introduces the SION™ Surgical Instrument – The First Bladeless Device Used in Goniotomy Read More »